WILMINGTON, Del. -- (Business Wire)
Association for Female Executives (NAFE) today named AstraZeneca
(NYSE: AZN) one of the top 50 companies for female executives for the
fifth consecutive year. AstraZeneca ranks second on this year’s list.
NAFE recognizes organizations for policies and practices that encourage
women’s advancement, and in particular, the number of women holding
executive positions in the business.
Within AstraZeneca, women lead key teams and functions, including the
executive vice president, human resources and corporate affairs; vice
president, global compliance strategy and assurance; vice president,
human resources, US; vice president, sales and marketing, Cornerstone
brands; and vice president, sales and marketing, Growth brands. All
US-based women representing US or global functions were considered in
the total submission on behalf of AstraZeneca.
“Our goal is to continue to strengthen and diversify our workforce,
including women, to ultimately reach their career goals and
aspirations,” said Deb Kauffman, Vice President, Human Resources, US.
“This recognition showcases AstraZeneca’s ongoing commitment to ensuring
we have the talent required to drive a successful business.”
AstraZeneca offers programs that contribute to a supportive working
culture for women, including:
Career development and mentoring programs, including support for
Diverse employee network groups, including the “AZ Network of Women”
Work/life resource and employee assistance programs providing
confidential, personal support, resources and referrals to help solve
a wide range of personal and work-related challenges
The National Association for Female Executives (NAFE), founded in 1972,
serves 20,000 members nationwide with networking, tools and solutions to
strengthen and grow their careers and businesses. Working
Mother magazine publishes the annual NAFE Top 50 list. NAFE.com
provides up-to-date information, community for women in business and
access to member benefits. NAFE is a division of Working Mother Media,
owned by the Bonnier Corporation.
AstraZeneca is a global, innovation-driven biopharmaceutical business
with a primary focus on the discovery, development and commercialization
of prescription medicines for gastrointestinal, cardiovascular,
neuroscience, respiratory and inflammation, oncology and infectious
disease. AstraZeneca operates in over 100 countries and its innovative
medicines are used by millions of patients worldwide.
For more information about AstraZeneca in the U.S. or our AZ&Me™
Prescription Savings programs, please visit: www.astrazeneca-us.com
or call 1-800-AZandMe (292-6363).
AstraZeneca Media Inquiries:
Tony Jewell, 302-885-4594
© 2016 Canjex Publishing Ltd. All rights reserved.